LLY

Eli Lilly & Co
D

LLY

Arincen80/100B

Eli Lilly & Co net income 1985–2026

Eli Lilly & Co earned 6.45B USD in Q3 FY2026, the three months to 30 September 2026, up 15.6% on the same quarter a year before. Eli Lilly & Co's net income over the last twelve months was 27.58B USD, up 49.8% on the twelve months before. In fiscal year 2025 it earned 20.64B USD, up 94.9% on the year before.

Last updated 10 Nov 2026 · Next report 3 Feb 2027

Net income

Net income · +24.0% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 202627.58B+49.79%31.90%86.46B
FY202531 Dec 202520.64B+94.90%31.67%65.18B
FY202431 Dec 202410.59B+102.08%23.51%45.04B
FY202331 Dec 20235.24B-16.08%15.36%34.12B
FY202231 Dec 20226.24B+11.88%21.88%28.54B
FY202131 Dec 20215.58B-9.88%19.71%28.32B
FY202031 Dec 20206.19B-25.54%25.24%24.54B
FY201931 Dec 20198.32B+157.38%37.27%22.32B
FY201831 Dec 20183.23B—15.04%21.49B
FY201731 Dec 2017-204.10M-107.46%-1.02%19.97B
FY201631 Dec 20162.74B+13.67%12.90%21.22B
FY201531 Dec 20152.41B+0.75%12.07%19.96B
FY201431 Dec 20142.39B-48.97%12.19%19.62B
FY201331 Dec 20134.68B+14.58%20.27%23.11B
FY201231 Dec 20124.09B-5.96%18.09%22.60B
FY201131 Dec 20114.35B-14.24%17.90%24.29B
FY201031 Dec 20105.07B+17.11%21.97%23.08B
FY200931 Dec 20094.33B—19.82%21.84B
FY200831 Dec 2008-2.07B-170.16%-10.17%20.37B
FY200731 Dec 20072.95B+10.90%15.85%18.63B
FY200631 Dec 20062.66B+34.51%16.97%15.69B
FY200531 Dec 20051.98B+9.36%13.52%14.65B
FY200431 Dec 20041.81B-29.32%13.06%13.86B
FY200331 Dec 20032.56B-5.43%20.35%12.58B
FY200231 Dec 20022.71B-2.59%24.45%11.08B
FY200131 Dec 20012.78B-9.08%24.08%11.54B
FY200031 Dec 20003.06B+12.38%28.15%10.86B
FY199931 Dec 19992.72B+29.70%27.20%10.00B
FY199831 Dec 19982.10B—22.71%9.24B
FY199731 Dec 1997-385.10M-125.28%-4.82%7.99B
FY199631 Dec 19961.52B-33.50%21.77%7.00B
FY199531 Dec 19952.29B+78.13%33.87%6.76B
FY199431 Dec 19941.29B+167.83%22.52%5.71B
FY199331 Dec 1993480.20M-32.24%7.44%6.45B
FY199231 Dec 1992708.70M-46.09%11.49%6.17B
FY199131 Dec 19911.31B+16.62%22.96%5.73B
FY199031 Dec 19901.13B+19.99%21.71%5.19B
FY198931 Dec 1989939.50M+23.46%22.50%4.18B
FY198831 Dec 1988761.00M+18.22%18.70%4.07B
FY198731 Dec 1987643.70M+15.32%17.67%3.64B
FY198631 Dec 1986558.20M+7.84%15.00%3.72B
FY198531 Dec 1985517.60M—15.83%3.27B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Eli Lilly & Co's profit

Source: Financial Modeling Prep